Search results
Feb 17, 2022 · Janet Woodcock is the FDA’s Principal Deputy Commissioner. In this role she works closely with the Commissioner of Food and Drugs to develop and implement key public health initiatives...
- Principal Deputy Commissioner
- Office of The Commissioner
Feb 7, 2024 · Dr. Woodcock embedded these principles in every FDA program and offices she directed. Among her numerous achievements, one of her most enduring impacts may stem from her white paper on the FDA’s Critical Path Initiative.
Oct 26, 2021 · Remarks by Janet Woodcock, M.D. Acting Commissioner of Food and Drugs FDA Pharmaceutical Quality Symposium 2021: Innovations in a Changing World October 26, 2021 White Oak, MD.
Tags: CDER , FDA , Janet , Woodcock. This Wednesday will be Dr. Janet Woodcock@s last day at the US Food and Drug Administration (FDA), capping a remarkable 38-year career at the agency. She@s been called one of the most powerful and influential drug regulators worldwide.
Nov 30, 2023 · November 30, 2023. Wayne Pines, Senior Director at APCO Worldwide, a former associate commissioner of the FDA, and a member of the FDAnews Editorial Board, offers his perspective on the extraordinary career of the FDA’s Principal Deputy Commissioner Janet Woodcock, who will retire in early 2024.
Sep 14, 2021 · Acting Commissioner of Food and Drugs. Third FDA Online Opioid Summit - Reducing the Availability of Opioids Online. September 9, 2021. Virtual. (Remarks as prepared for delivery) Good morning....
Jan 29, 2024 · Zachary Brennan. Senior Editor. For almost four decades, Janet Woodcock has served in nearly every major leadership position at the FDA — acting commissioner, deputy...
